The Fenway Institute
16
1
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
25%
4 trials in Phase 3/4
23%
3 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
Role: collaborator
Comparative Effectiveness of Individual Versus Group-Level Interventions to Increase PrEP Uptake and Reduce HIV/STI Incidence
Role: collaborator
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV
Role: collaborator
Harmonized Healing: Personalized Music Interventions to Address Chronic Pain in People Living With HIV
Role: collaborator
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)
Role: collaborator
Pre-exposure Prophylaxis (PrEP) for Health
Role: collaborator
Next Generation Ingestible Sensors for Medication Adherence Measurement
Role: collaborator
Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse
Role: collaborator
TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
Role: collaborator
Trauma Informed Intervention to Support Engagement in HIV Care Among MSM (THRIVE+)
Role: collaborator
P3 (Prepared, Protected, emPowered)
Role: collaborator
Optimizing HIV PrEP Through Shared Decision Making
Role: collaborator
Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade
Role: collaborator
TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru
Role: collaborator
Body Image and Self-Care in HIV-Infected MSM
Role: collaborator
Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS
Role: collaborator
All 16 trials loaded